Innovative Science
The drugs in our pipeline offer a new mechanism focused on PDE4B and PDE4D.
Tetra In The News
See how Tetra is making progress developing new medicines to treat cognitive impairment.
Strategic Partnerships
FRAXA Research Foundation, The Alzheimer’s Drug Discovery Foundation, and NIH Blueprint Therapeutics are partnering with us.
Our Mission
Treat cognitive impairment and memory loss by improving how the brain processes and stores information. Working with potentially breakthrough technology, our goal is to improve the quality of life in patients suffering from:
Fragile X Syndrome | Alzheimer’s Disease | Dementias
Traumatic Brain Injury | Major Psychiatric Diseases